https://www.biospace.com/oncomyx-announces-presentation-of-preclinical-efficacy-data-of-novel-oncolytic-immunotherapy-at-sitc-2020
OncoMyx Announces Presentation of Preclinical Efficacy Data of Novel Oncolytic Immunotherapy at...
Nov 9, 2020 - OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, announced the presentation of preclinical data at the Society for Immunotherapy of...
oncolytic immunotherapyannouncespresentationpreclinical
https://pmc.ncbi.nlm.nih.gov/articles/PMC3989763/
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity - PMC
Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both oncolysis and elicited antitumor immunity. OVs induce mostly...
https://www.mdpi.com/books/reprint/5203-oncolytic-virus-immunotherapy
Oncolytic Virus Immunotherapy | MDPI Books
Dear Readers, Oncolytic Viruses (OV) are self-propagating agents that can selectively induce the lysis of cancer cells while sparing normal tissues....
oncolytic virusimmunotherapymdpibooks
https://www.news-medical.net/news/20240806/Harnessing-oncolytic-viruses-for-cancer-immunotherapy-to-improve-treatment-outcomes.aspx
Harnessing oncolytic viruses for cancer immunotherapy to improve treatment outcomes
Aug 6, 2024 - Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target malignant...
oncolytic virusescancer immunotherapyharnessingimprovetreatment
https://pmc.ncbi.nlm.nih.gov/articles/PMC8987060/
Engineering strategies to enhance oncolytic viruses in cancer immunotherapy - PMC
Oncolytic viruses (OVs) are emerging as potentially useful platforms in treatment methods for patients with tumors. They preferentially target and kill tumor...
oncolytic virusescancer immunotherapyengineeringstrategiesenhance
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1490414/full
Frontiers | Neutrophils in oncolytic virus immunotherapy
Oncolytic viruses have emerged as a highly promising modality for cancer treatment due to their ability to replicate specifically within tumors, carry therap...
oncolytic virusfrontiersneutrophilsimmunotherapy
https://www.mdpi.com/2072-6694/13/3/544
Measles Virus as an Oncolytic Immunotherapy
Measles virus (MeV) preferentially replicates in malignant cells, leading to tumor lysis and priming of antitumor immunity. Live attenuated MeV vaccine strains...
measles virusoncolyticimmunotherapy
https://www.lytixbiopharma.com/
Lytix Biopharma | Oncolytic Immunotherapy
Lytix Biopharma is developing first-in-class oncolytic molecule therapies that kill cancer with direct and abscopal tumor effects. Redefining the standard of...
lytixbiopharmaoncolyticimmunotherapy